Wilma J Teubel Selected Research

Androgens

12/2023	Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolites.
11/2023	Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.
1/2022	Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.
1/2022	Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wilma J Teubel Research Topics

Disease

7	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2011
3	Neoplasms (Cancer) 11/2023 - 01/2011
1	Infections 01/2011

Drug/Important Bio-Agent (IBA)

6	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 01/2019
4	AndrogensIBA 12/2023 - 01/2022
2	abirateroneIBA 01/2022 - 01/2019
1	Testosterone (Sustanon)FDA Link 12/2023
1	Cyclin-Dependent Kinase Inhibitor p21IBA 11/2023
1	taxaneIBA 11/2023
1	Docetaxel (Taxotere)FDA Link 11/2023
1	Taxoids (Taxanes)IBA 11/2023
1	darolutamideIBA 11/2023
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	Hormones (Hormone)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Cytochrome P450 Family 17IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2011

Therapy/Procedure

3	Castration 11/2022 - 01/2019
1	Combined Modality Therapy 11/2023
1	Drug Therapy (Chemotherapy) 11/2023
1	Therapeutics 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2011